The anti-ischemia agent ranolazine promotes the development of intestinal tumors in APC(Min/+) mice

Mark A. Suckow, Linda S. Gutierrez, Christina A. Risatti, William R. Wolter, Richard E. Taylor, Morris Pollard, Rudolph M. Navari, Francis J. Castellino, Nicholas F. Paoni

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'The anti-ischemia agent ranolazine promotes the development of intestinal tumors in APC(Min/+) mice'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry